Taro Pharmaceuticals just announced that they have partnered with BioPlus as the exclusive dispenser of the new specialty generic medication deferiprone.
Deferiprone (the generic form of Ferriprox®) treats transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate. Thalassemia is a genetic-based group of blood disorders that can cause anemia due to changes in hemoglobin.
Although thalassemia syndromes are considered rare in the United States, they are still the most common autosomal recessive disorders. These syndromes affect an estimated 1 in 100,000 people. Even with treatment, these syndromes can be associated with the complication of iron overload, due to frequent blood transfusions.
If you’re looking for a generic iron chelator option for your patients with thalassemia syndromes, know that deferiprone is now here and available from BioPlus. Thank you, Taro Pharmaceuticals for choosing BioPlus as the exclusive distributor of this medication. And, as always, you can count on BioPlus for the specialty pharmacy medications your patients need.
Related Posts
Psoriasis Social Stigma
More than 8 million Americans experience the uncomfortable, chronic skin condition of psoriasis....
VIDEO - The Facts About Lung Cancer
The Facts About Lung Cancer
November is Lung Cancer Awareness Month. Learn more about preventing...
Relief for Post-Shingles Pain
The painful rash and blistering scabs of shingles cause a huge amount of discomfort in the United...
For Those with Psoriasis…How’s Your Liver?
When you think of psoriasis, you probably think about the skin. It is true that this disease...